首站-论文投稿智能助手
典型文献
Potential Mechanisms and Effects of Chinese Medicines in Treatment of Diabetic Atherosclerosis by Modulating NLRP3 Inflammasome:A Narrative Review
文献摘要:
Nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing 3(NLRP3)is an intracellular sensor that detects endogenous danger signals and environmental irritants to assemble into the NLRP3 inflammasome.Activation of the NLRP3 inflammasome leads to the secretion of the proinflammatory cytokines interleutkin(IL)-1 β and IL-18 and induces pyroptosis.Recent studies have shown that the NLRP3 inflammasome participates in the initiation and progression of diabetic atherosclerosis through pathological mechanisms such as β-cell dysfunction,insulin resistance,endothelial cell dysfunction,monocyte adhesion and infiltration,and smooth muscle cell proliferation and migration.In diabetic atherosclerosis,Chinese medicine has been proven effective for the inflammatory response mediated by the NLRP3 inflammasome.This review summarizes the latest progress on the NLRP3 inflammasome in the pathogenesis and potential Chinese medicine treatment of diabetic atherosclerosis.
文献关键词:
作者姓名:
YUAN Jia-yao;FU Yu;FENG Zhi-hai;SANG Feng;SHAO Ming-yi;LI Lei-lei
作者机构:
School of First Clinical,Henan University of Chinese Medicine,Zhengzhou(450000),China;Department of Endocrinology,The First Affiliated Hospital of Henan University of Chinese Medicine,Zhengzhou(450000),China;Department of Key Laboratory of Viral Diseases Prevention and Treatment of Traditional Chinese Medicine of Henan Province,The First Affiliated Hospital of Henan University of Chinese Medicine,Zhengzhou(450000),China;Department of Gastroenterology,The First Affiliated Hospital of Henan University of Chinese Medicine,Zhengzhou(450000),China
引用格式:
[1]YUAN Jia-yao;FU Yu;FENG Zhi-hai;SANG Feng;SHAO Ming-yi;LI Lei-lei-.Potential Mechanisms and Effects of Chinese Medicines in Treatment of Diabetic Atherosclerosis by Modulating NLRP3 Inflammasome:A Narrative Review)[J].中国结合医学杂志(英文版),2022(08):753-761
A类:
Inflammasome,irritants,interleutkin
B类:
Potential,Mechanisms,Effects,Chinese,Medicines,Treatment,Diabetic,Atherosclerosis,by,Modulating,NLRP3,Narrative,Review,Nucleotide,binding,oligomerization,domain,like,receptor,family,pyrin,containing,intracellular,sensor,that,detects,endogenous,danger,signals,environmental,assemble,into,inflammasome,Activation,leads,secretion,proinflammatory,cytokines,induces,pyroptosis,Recent,studies,have,shown,participates,initiation,progression,diabetic,atherosclerosis,through,pathological,mechanisms,such,dysfunction,insulin,resistance,endothelial,monocyte,adhesion,infiltration,smooth,muscle,proliferation,migration,medicine,has,been,proven,effective,response,mediated,This,review,summarizes,latest,pathogenesis,potential,treatment
AB值:
0.630378
相似文献
Effect of electroacupuncture on inflammatory signal expression in local tissues of rats with chronic pelvic pain syndrome based on purinergic 2X7 receptor/NOD-like receptor pyrin domain-containing 3 signal pathway
XU Chang;LI Na;WU Xiaoling;DAI Xingye;YANG Zhiwen;SUN Qianhui;SHI Tianyu;CHAI Yemao;PANG Dandan;CHENG Kai-Major in Acupuncture and Tuina,school of Acupuncture and Tuina,Beijing University of Chinese Medicine,Beijing 100029,China;Experimental science of acupuncture and moxibustion teaching and research section,school of Acupuncture and Tuina,Beijing University of Chinese Medicine,Beijing 100029,China;Complex laboratory,school of Acupuncture and Tuina,Beijing University of Chinese Medicine,Beijing 100029,China;Academy of Chinese Medical Sciences,Beijing 100700,China;Meridians and acupoints teaching and research section,school of Acupuncture and Tuina,Beijing University of Chinese Medicine,Beijing 100029,China
Mongolian medicine in treating type 2 diabetes mellitus combined with nonalcoholic fatty liver disease via FXR/LXR-mediated P2X7R/NLRP3/NF-κB pathway activation
Shuyin Bao;Xiuzhi Wang;Qianqian Ma;Chengxi Wei;Jixing Nan;Wuliji Ao-Institute of Pharmaceutical Chemistry and Pharmacology,Inner Mongolia Minzu University,Tongliao 028000,China;Inner Mongolia Key Laboratory of Mongolian Medicine Pharmacology for Cardio-Cerebral Vascular System,Tongliao 028000,China;Jilin Key Laboratory for Traditional Chinese Korean Medicine,College of Pharmacy,Yanbian University,Yanji 133002,China;Department of Medicines and Foods,Tongliao Vocational College,Tongliao 028000,China;Research and development center,Inner Mongolia Research Institute of Traditional Mongolian Medicine Engineering Technology,Tongliao 028000,China;Mongolian Medicine R&D National Local Union Engineering Research Center,Inner Mongolia Minzu University,Tongliao 028000,China
Taxifolin attenuates inflammation via suppressing MAPK signal pathway in vitro and in silico analysis
Xingyan Zhang;Xiaoyan Lian;Huling Li;Wenjing Zhao;Xin Li;Fujun Zhou;Yutong Zhou;Tao Cui;Yuli Wang;Changxiao Liu-Key Laboratory of Quality-marker of Traditional Chinese Medicines,Tianjin Institute of Pharmaceutical Research Co.,Ltd.,Tianjin 300462,China;Center for Drug Evaluation,National Medical Products Administration,Beijing 100022,China;Department of Pharmacology,Tianjin Medical University,Tianjin 300070,China;State Key Laboratory of Drug Delivery Technology and Pharmacokinetics,Tianjin Institute of Pharmaceutical Research Co.,Ltd.,Tianjin 300462,China;Key Laboratory of Systems Bioengineering(Ministry of Education),School of Chemistry Engineering and Technology,Tianjin University,Tianjin 300072,China;Pharmaceuticai Armaceuticai DA REN TANG Group Corporation Limited Traditional Chinese Pharmacy Researchinstitute,Tianjin 300457,China;Tianjin Key Laboratory of Quality Control in Chinese Medicine,Tianjin 300457,China;Research Unit for Drug Metabolism,Chinese Academy of Medical Sciences,Beijing 100730,China
Progression of the Wei?Qi?Ying?Xue Syndrome, Microcirculatory Disturbances, in Infectious Diseases and Treatment with Traditional Chinese Medicine
Jing?Yan Han;Quan Li;Chun?Shui Pan;Kai Sun;Jing?Yu Fan-Department of Integration of Chinese and Western Medicine,School of Basic Medical Sciences,Peking University,Beijing,People's Republic of China;Academy of Integration of Chinese and Western Medicine,Peking University Health Science Center,Beijing,People's Republic of China;Tasly Microcirculation Research Center,Peking University Health Science Center,Beijing,People's Republic of China;Department of Integration of Chinese and Western Medicine,Peking University,Key Laboratory of Stasis and Phlegm,State Administration of Traditional Chinese Medicine of the People's Republic of China,Beijing,People's Republic of China;Department of Integration of Chinese and Western Medicine,Peking University,Beijing Laboratory of Integrative Microangiopathy,Beijing,People's Republic of China;Department of Integration of Chinese and Western Medicine,Peking University,State Key Laboratory of Core Technology in Innovative Chinese Medicine,Beijing,People's Republic of China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。